🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/04/1970 | 1,31 | 1,32 | 1,28 | 1,31 | +0,25% | 2,78% | 1.652.486 |
| 13/04/1970 | 1,33 | 1,33 | 1,30 | 1,31 | -1,37% | 2,25% | 1.033.747 |
| 10/04/1970 | 1,33 | 1,34 | 1,32 | 1,33 | -0,13% | 0,87% | 913.018 |
| 09/04/1970 | 1,36 | 1,38 | 1,33 | 1,33 | -1,96% | 3,91% | 3.101.242 |
| 08/04/1970 | 1,32 | 1,36 | 1,32 | 1,36 | +2,38% | 2,38% | 716.832 |
| 07/04/1970 | 1,32 | 1,32 | 1,31 | 1,32 | +0,38% | 1,13% | 739.469 |
| 06/04/1970 | 1,33 | 1,34 | 1,32 | 1,32 | -0,51% | 1,50% | 747.014 |
| 03/04/1970 | 1,35 | 1,35 | 1,32 | 1,33 | -1,84% | 2,08% | 1.139.386 |
| 02/04/1970 | 1,36 | 1,36 | 1,35 | 1,35 | -0,37% | 0,86% | 528.192 |
| 01/04/1970 | 1,35 | 1,37 | 1,35 | 1,36 | +0,24% | 1,47% | 1.003.565 |
| 31/03/1970 | 1,36 | 1,36 | 1,34 | 1,35 | -1,57% | 1,34% | 1.192.205 |
| 30/03/1970 | 1,38 | 1,39 | 1,37 | 1,37 | -0,36% | 1,68% | 565.920 |
| 26/03/1970 | 1,38 | 1,38 | 1,37 | 1,38 | +0,00% | 1,09% | 1.101.658 |
| 25/03/1970 | 1,35 | 1,40 | 1,35 | 1,38 | +2,97% | 3,69% | 1.139.386 |
| 24/03/1970 | 1,33 | 1,36 | 1,33 | 1,34 | +1,63% | 2,24% | 1.592.122 |
| 23/03/1970 | 1,31 | 1,32 | 1,29 | 1,32 | +0,63% | 2,15% | 505.555 |
| 20/03/1970 | 1,34 | 1,35 | 1,29 | 1,31 | -2,47% | 4,69% | 1.335.571 |
| 19/03/1970 | 1,34 | 1,36 | 1,33 | 1,34 | +0,00% | 2,47% | 1.275.206 |
| 18/03/1970 | 1,31 | 1,34 | 1,31 | 1,34 | +3,31% | 2,53% | 1.531.757 |
| 17/03/1970 | 1,29 | 1,30 | 1,29 | 1,30 | +0,78% | 0,90% | 1.146.931 |
| 16/03/1970 | 1,30 | 1,30 | 1,29 | 1,29 | -1,27% | 1,14% | 1.788.307 |
| 13/03/1970 | 1,32 | 1,32 | 1,29 | 1,31 | -3,43% | 2,01% | 3.463.430 |
| 12/03/1970 | 1,37 | 1,37 | 1,33 | 1,35 | -1,92% | 2,90% | 1.403.482 |
| 11/03/1970 | 1,38 | 1,38 | 1,37 | 1,38 | -0,48% | 1,44% | 1.026.202 |
| 10/03/1970 | 1,40 | 1,41 | 1,35 | 1,38 | -1,18% | 4,25% | 1.252.570 |
| 09/03/1970 | 1,41 | 1,41 | 1,39 | 1,40 | -0,82% | 0,94% | 701.741 |
| 06/03/1970 | 1,41 | 1,42 | 1,41 | 1,41 | +0,36% | 0,47% | 452.736 |
| 05/03/1970 | 1,42 | 1,43 | 1,41 | 1,41 | -0,94% | 1,63% | 558.374 |
| 04/03/1970 | 1,43 | 1,44 | 1,42 | 1,42 | -0,46% | 1,16% | 830.016 |
| 03/03/1970 | 1,42 | 1,43 | 1,41 | 1,43 | +0,23% | 1,63% | 1.350.662 |